Get powerful technology with a proven ROI:

stopwatch_icon-03

Accelerate projects by selecting reagents and model systems in 30 seconds vs. 12 weeks

dollar_icon-04

Reduce hard cost of consumables and save millions per year

Microscope_Icon

Empower organizational purpose by restoring research time to scientists

Brain_Icon

See real business impact from AI with a proven, turnkey application

Antibodies were just the beginning

Backed by Google’s AI fund, Gradient Ventures, ASCEND is the industry standard for antibody selection.

Over 50,000 scientists in 16 of the top 20 pharmaceutical companies and more than 4,500  academic institutions use ASCEND to navigate antibody data to plan more successful experiments, with proven savings of millions per year in hard costs alone. But antibodies constitute just 40-50% of reagent failures.

Donut Chart Desktop
Donut Chart Mobile

The interface

BenchSci Reagent Platform Demo

Make more informed experiment design decisions

Select the appropriate products in seconds while avoiding unnecessary and redundant development and validation work.

Read More

What began with antibody selection now encompasses additional reagents as well as model systems, including:

Antibodies

Representing about 40-50% of reagent waste, with millions of products and hundreds of vendors

Recombinant proteins

Often the second highest source of waste after antibodies, with a similar number of products and vendors

RNAi

Challenging to search for, with many not cited by SKU, and a need to find through other means such as sequence

Cell lines

Critical tools whose common misidentification and misuse can have a devastating impact on research projects

CRISPR

One of the most important new gene-editing technologies, with the need to select vectors, nuclease, guide RNA, screening libraries, and trans-activating RNA

Animal Models

Time-consuming to find—scientists often consult many papers to identify a model that has been successfully utilized in experiments similar to their own

PCR

A crucial advancement in molecular biology that enables scientists to better understand a specific gene function

Trust in comprehensive open- and closed-access data

Get comprehensive experimental evidence, reagent and model system catalog data, and independent validations within a single intuitive interface.

Read More

Get rapid adoption with an exceptionally intuitive interface

Designed by scientists, the platform's intuitive interface requires minimal training and is adopted quickly within organizations.

Read More

Deploy unparalleled biomedical AI technology with minimal effort

Extract and contextualize data from the world’s scientific literature, all in the cloud.

Read More

See how ASCEND can reduce consumable costs and accelerate projects in your organization

Request a Demo

Learn more about ASCEND